22 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes
6-K
EX-1.1
eqr176s
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
tuyav
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
y6yoaygnwsrr 5iykj05
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
3kjgmreg1wl6 au
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
ue3ikh
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.2
bom6pkm5g8zoa1 abh
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
0n8cnx clrw
19 Nov 18
Agreement and Plan of Merger
4:34pm
424B5
6ytp5ax
18 Mar 16
Prospectus supplement for primary offering
12:00am
20-F
r6h2v2dp1teggogp8pb
31 Mar 15
Annual report (foreign)
12:00am